MED19, mediator complex subunit 19, 219541

N. diseases: 50; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 Biomarker group BEFREE Accumulating evidence has shown that Med19 plays important roles in cancer cell proliferation and tumorigenesis. 28337304 2017
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 Biomarker group BEFREE Including BC-associated SNPs in risk assessment can provide more accurate risk prediction than family history alone and can influence recommendations for cancer screening and prevention modalities for high-risk women.Genet Med 19 1, 30-35. 27171545 2017
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 Biomarker group BEFREE Accumulating evidence has shown that Med19 plays important roles in cancer cell proliferation and tumorigenesis. 25735376 2015
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 AlteredExpression group BEFREE The data showed that the expression of MED19 in human ovarian cancer tissues correlated with the level of tumor malignancy. 22961438 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 AlteredExpression group BEFREE Expression of Med19 was associated with tumor size, cancer cell differentiation, and TNM stages (P<0.05). 22565189 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 Biomarker group BEFREE These results provide new evidence of an important role for Med19 in the development of hepatocellular carcinomas, suggesting that lentivirus-mediated RNAi to target Med19 is a potential tool for inhibiting cancer cell proliferation and tumorigenesis. 21372827 2011
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 Biomarker group BEFREE This study provides a potent role of MED19 in promoting pancreatic cancer growth and a possible drug target for cancer therapy. 21834715 2011